Identifying patterns of DNA for tumor diagnosis using capillary electrophoresis-amplified fragment length polymorphism (CE-AFLP) screening

Journal of Bioinformatics and Computational Biology

Volumn 2, Issue 3, 2004, Pages 569-587

  Wong, Kee Yew ^a   Chuan, Yin Choy ^a   Aggarwal, Amit ^a   Tham, Lawrence ^b   Kong, Wai Ming ^b   Tan, Patrick ^a  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b SCHOOL OF ENGINEERING   (Singapore)

Author keywords

CE AFLP; Class prediction; DNA marker pattern; Gastric cancer; Genomics

Indexed keywords

DNA; DNA MARKER; GENOMIC DNA;

AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ARTICLE; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER SCREENING; CAPILLARY ELECTROPHORESIS; CLINICAL PROTOCOL; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DNA DETERMINATION; DNA FINGERPRINTING; DNA SEQUENCE; FEMALE; GENE CLUSTER; GENE MUTATION; GENOTYPE; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; STOMACH TUMOR;

ALGORITHMS; DIAGNOSIS, COMPUTER-ASSISTED; DNA FINGERPRINTING; DNA, NEOPLASM; ELECTROPHORESIS, CAPILLARY; FEMALE; GENETIC SCREENING; HUMANS; MALE; PATTERN RECOGNITION, AUTOMATED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; STOMACH NEOPLASMS;

EID: 4644350423     PISSN: 02197200     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0219720004000740     Document Type: Article

References (18)

1. Ferlay J, Bray F, Pisani P, Parkin DM, GLOBOCAN 2000: Cancer, Incidence, Mortality and Prevalence Worldwide, IARC Press, Lyon, 2001.
2. Wu CW, Hsieh MC, Lo SS, Tsay SH, Li AF, Lui WY, Peng FK, Prognostics indicators for survival after curative resection for patients with carcinoma of stomach, Digest Dis Sci 42:1265-1269, 1997.
3. Pisani P, Oliver WE, Parkin DM, Alvarez N, Vivas J, Case-control study of gastric cancer screening in Venezuela, Brit J Cancer 69(6):1102-1105, 1994.
4. Fukao A, Tsubono Y, Tsuji I, Hisamichi S, Sugahara N, Takano A, The evaluation of screening for gastric cancer in Miyagi Prefecture, Japan: a population-based case-control study, Int J Cancer 60(1):45-48, 1995.
5. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, Boldrick JC, Sabet H, Tran T, Yu X, et al., Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling, Nature (Lond) 403:503-511, 2000.
6. Bittner M, Meltzer P, Chen Y, Jiang Y, Seftor E, Hendeix M, Radmacher MM, Simon R, Yakhini Z, Ben-Dor A, et al., Molecular classification of cutaneous malignant melenoma by gene expression profiling, Nature (Lond) 406:536-540, 2000.
7. Vos P, Hogers R, Bleeker M, Reijans M, van de Lee T, Hornes M, Frijters A, Pot J, Peleman J, Kuiper M, AFLP: a new technique for DNA fingerprinting, Nucleic Acids Res 23:4407-4414, 1995.
8. Jonas D, Meyer HW, Matthes P, Hartung D, Jahn B, Daschner FD, Jansen B, Comparative evaluation of three different genotyping methods for investigation of nosocomial outbreaks of legionnaires' disease in hospitals, J Clin Microbiol 38(6):2284-2291, 2000.
9. Williams KJ, Smyl L, Lichon A, Wong KY, Wallwork H, Development and use of an assay based on the polymerase chain reaction that differentiates the pathogens causing spot form and net form of net blotch of barley, Australas Plant Path 30:37-44, 2001.
10. Prochazka M, Walder K, Xia J, AFLP fingerprinting of the human genome, Hum Genet 108:59-65, 2001.
11. Tay ST, Leong SH, Kun Yu, Aggarwal A, Tan SY, Lee CH, Wong K, Visvanathan J, Lim D, Wong WK, Soo KC, Kon OL, Tan P, A combined comparative genomic hybridization and expression microarray analysis of gastric cancer reveals novel molecular subtypes, to appear in Cancer Res, 2003.
12. Varis A, Wolf M, Monni O, Vakkari ML, Kokkola A, Moskaluk C, Frierson H, Powell SM, Knuutila S, Kallioniemi A, et al., Targets of gene amplification and overexpression at 17q in gastric cancer, Cancer Research 62:2625-2629, 2002.
13. Papadakis EN, Dokianakis DN, Spandidos DA, p53 codon 72 polymorphism as a risk factor in development of breast cancer, Mol Cell Biol Res Commun 3(6):389-392, 2000.
14. Golub TR, Slonim DK, Tamayo P, Huard C, Gaasenbeek M, Mesirov JP, et al., Molecular classification of cancer: class discovery and class prediction by gene expression monitoring, Science 286:531-537, 1999.
15. Mitelman F, Catalogue of Chromosome Aberrations in Cancer, Wiley, New York, 1994.
16. Mertens F, Johansson B, Hoeglund M, Mitelman F, Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms, Cancer Res 57: 2765-2780, 1997.
17. Singh KP, Roy D, Identification of novel breast tumor-specific mutation(s) in the q11.2 region of chromosome 17 by RAPD/AP-PCR fingerprinting, Gene 269:33-43, 2001.
18. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, et al., Use of proteomic patterns in serum to identify ovarian cancer, Lancet 359(9306):572-577, 2002.